Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adaflex 2mg tablets
0401010ADBGABBK
|
Adaflex | Melatonin | Central Nervous System | 6,527 |
|
Adaflex 3mg tablets
0401010ADBGACCY
|
Adaflex | Melatonin | Central Nervous System | 2,462 |
|
Adaflex 4mg tablets
0401010ADBGADCP
|
Adaflex | Melatonin | Central Nervous System | 2,117 |
|
Adaflex 5mg tablets
0401010ADBGAEBL
|
Adaflex | Melatonin | Central Nervous System | 1,681 |
|
Adaflex 1mg tablets
0401010ADBGAAAI
|
Adaflex | Melatonin | Central Nervous System | 1,509 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.